U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

A common malaria drug could be repurposed to treat a variety of hematologic cancers and solid tumors, according to early ...

The global antiviral drugs market is poised for steady expansion, projected to reach a valuation of USD 89.68 billion by 2033, up from USD 61.42 billion in 2023, growing at a Comp ...

The US giants which supply vital new medicines to UK patients face disruption from Donald Trump’s trade barriers, experts ...

Team is now exploring a clinical trial and investigating whether other existing drugs could alleviate endometriosis symptoms ... Fattori and Rogers are inventors on patent PCT/US2023/079238.

Preclinical data presented at Obesity Week in Texas, US in November 2024 suggested that combining LX9851 with Novo Nordisk’s flagship drug semaglutide, marketed as Ozempic in type 2 diabetes and ...

The technology claims to identify common drugs of abuse through fingerprint sweat analysis. Credit: Kamon_wongnon / Shutterstock. Intelligent Bio Solutions (INBS) has secured a new US patent for the ...

The Food and Drug Administration on Tuesday approved GSK ... to make up for lost revenues from its best-selling medicines and looming patent losses for its HIV treatments. Over half of all ...

The patent system was designed to promote innovation, and the Hatch-Waxman Act and BPCIA balanced innovation and access to small molecule drugs and biologics. The former president, the USPTO, and ...

Patients with Spinal Muscular Atrophy (SMA) are hopeful of getting access to generic versions of Roche’s patented drug Risdiplam ... within the scope of Indian Patent law.” ...

Regular pipeline setbacks, slow ramp-up of newer drugs, patent cliffs, regulatory risks and broader market concerns related to the economy are some of the headwinds for the sector. There remains ...

After treatment, the mice stayed seizure-free for two months, according to the paper. Collaborators ... Roopra have also filed for a patent on the use of the drug in epilepsy.